Barclays PLC Beyond Spring Inc. Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Beyond Spring Inc. stock. As of the latest transaction made, Barclays PLC holds 4 shares of BYSI stock, worth $9. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4
Previous 4
-0.0%
Holding current value
$9
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding BYSI
# of Institutions
24Shares Held
5.44MCall Options Held
30.3KPut Options Held
1.8K-
Decheng Capital LLC Menlo Park, CA4.96MShares$12.1 Million2.37% of portfolio
-
Black Rock Inc. New York, NY215KShares$527,1490.0% of portfolio
-
Capstone Capital Wealth Advisors Henderson, NV50.5KShares$123,7250.16% of portfolio
-
State Street Corp Boston, MA32.2KShares$78,8900.0% of portfolio
-
Y Intercept (Hong Kong) LTD30.7KShares$75,1580.01% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $95.4M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...